Higher Risk Of Meningioma Side Effects Associated With Depo-Provera for These Women, According to a 2025 Medical Study Report
(Posted by Tom Lamb at Drug Injury Watch)
A recent medical study looking at Depo-Provera meningioma cases in the US
Drug Injury Watch
Drug Injury Watch, published by the Law Offices of Thomas J. Lamb, P.A., focuses on legal and medical information related to adverse effects and injuries caused by prescription drugs. The blog covers topics such as drug recalls, side effects, and emerging drug injury lawsuits involving medications like Andexxa, Wegovy, Ozempic, Dupixent, and Depo-Provera. It provides updates on medical studies linking drugs to specific injuries, FDA actions, and legal claims for compensation. The site emphasizes individual drug injury cases rather than class actions, offering free case evaluations and insights from attorney Tom Lamb based on extensive experience in drug injury litigation.
Latest from Drug Injury Watch - Page 3
Wegovy and Ozempic Increase NAION Risk, an Eye Side Effect That Can Result in Blindness
By Tom Lamb
Semaglutide is the Active Ingredient in These GLP-1 Drugs Used for Diabetes or Weight Loss
(Posted by Tom Lamb at Drug Injury Watch)
Over the past year, we have written several articles that reference medical reports concerning how the…
Dupixent Lawsuits Being Filed for Patients: Medical Information and Legal Allegations
By Tom Lamb
These Dupixent Cases Involving T-cell Lymphoma Cancer Are Against Regeneron Pharmaceuticals and Sanofi-Aventis
(Posted by Tom Lamb at Drug Injury Watch)
We are currently investigating possible Dupixent lawsuits for patients who were diagnosed with a relatively rare cancer, T-cell…
Dupixent Drug Injury Lawsuits For Patients Diagnosed With CTCL Cancer
By Tom Lamb
Cutaneous T-cell Lymphoma (CTCL) Cancer Includes Mycosis Fungoides And Sézary Syndrome
(Posted by Tom Lamb at Drug Injury Watch)
A growing body of medical evidence showing an association between Dupixent and cutaneous T-cell lymphoma (CTCL) has given rise to…
More Evidence For Increased Risk of NAION With Ozempic or Mounjaro in Diabetes Patients
By Tom Lamb
NAION is Likely Associated With Other Semaglutide or Tirzepatide GLP-1RA Drugs Used for Weight Loss
(Posted by Tom Lamb at Drug Injury Watch)
A new medical article published August 11, 2025, online by JAMA Network Open, “
(Posted by Tom Lamb at Drug Injury Watch)
A new medical article published August 11, 2025, online by JAMA Network Open, “
…
Current FDA Safety Investigation: NAION With Mounjaro, Zepbound, and Other GLP-1 RAs
By Tom Lamb
Evaluating Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Possible Risk of NAION Side Effects
(Posted by Tom Lamb at Drug Injury Watch)
The FDA has been investigating “potential signals” of non-arteritic anterior ischemic optic neuropathy (NAION) with the
(Posted by Tom Lamb at Drug Injury Watch)
The FDA has been investigating “potential signals” of non-arteritic anterior ischemic optic neuropathy (NAION) with the
…
Advisory: AION Vision Side Effect: Ozempic, Wegovy, Rybelsus
By Tom Lamb
The Eye Condition AION Diagnosis Can Include NAION Due to Semaglutide Use
(Posted by Tom Lamb at Drug Injury Watch)
This article discusses a lesser-known possible vision side effect for Ozempic, Wegovy, and Rybelsus, diagnosed as anterior
(Posted by Tom Lamb at Drug Injury Watch)
This article discusses a lesser-known possible vision side effect for Ozempic, Wegovy, and Rybelsus, diagnosed as anterior
…
Ozempic Vision Loss Lawsuits Have Been Filed by Patients Against Novo Nordisk
By Tom Lamb
We List Some of the Legal Liability Allegations Regarding Drug Company Actions and Failures
(Posted by Tom Lamb at Drug Injury Watch)
During the past several weeks, Ozempic vision loss lawsuits have been filed by patients against
(Posted by Tom Lamb at Drug Injury Watch)
During the past several weeks, Ozempic vision loss lawsuits have been filed by patients against
…
March 2025 Medical Article About Blindness or Vision Loss Linked to Ozempic and Rybelsus Use by Diabetes Patients
By Tom Lamb
Discusses Timing for Increased Risk of Semaglutide-related Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Side Effect
(Posted by Tom Lamb at Drug Injury Watch)
On March 27, 2025, the JAMA Ophthalmology medical journal published a report about a
(Posted by Tom Lamb at Drug Injury Watch)
On March 27, 2025, the JAMA Ophthalmology medical journal published a report about a
…
Ozempic Vision Problems From Semaglutide Apply to Wegovy and Rybelsus, Also
By Tom Lamb
NAION Eye Side Effect Risk Increased With Semaglutide Drugs – Two Recent Medical Studies
(Posted by Tom Lamb at Drug Injury Watch)
Two recent medical studies again link the eye side effect of non-arteritic anterior ischemic optic
(Posted by Tom Lamb at Drug Injury Watch)
Two recent medical studies again link the eye side effect of non-arteritic anterior ischemic optic
…